BENZINGA Chicago Interviews: Ngaio Bealum: Director of Development: ICBC
About the Author: HCN News Team
The News Team at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.
Related Posts
Latest News
Republican State AGs Challenge Trump’s Cannabis Rescheduling Directive
LOS ANGELES – A coalition of Republican attorneys general from eight states has publicly rejected President Donald Trump's recent Executive Order to reschedule Cannabis under the Controlled Substances Act, citing persistent risks to public safety ...
Banks Still Hesitant on Expanding Services for Cannabis Businesses Post-Trump Rescheduling Order
LOS ANGELES – President Donald Trump's Executive Order fast-tracked the move to reschedule Cannabis under the Controlled Substances Act, aiming to ease research barriers and tax deductions for state-legal operators. Yet even as this policy ...
Atai Gains Nasdaq Biotechnology Index Spot
NEW YORK – AtaiBeckley N.V., the clinical-stage biopharmaceutical firm born from the November merger of atai Life Sciences and Beckley Psytech, has secured a place in the Nasdaq Biotechnology Index (NBI), a move that underscores ...
